Value of current chemotherapy and surgery in advanced and metastatic bladder cancer

Urologia Internationalis
M RacioppiP F Bassi

Abstract

The aim of the present paper was to review findings from the most relevant studies and to evaluate the value of current chemotherapy and surgery in advanced unresectable and metastatic bladder cancer. Studies were identified by searching the MEDLINE® and PubMed® databases up to 2011 using both medical subject heading (Mesh) and a free text strategy with the name of the known individual chemotherapeutic drug and the following key words: 'muscle-invasive bladder cancer', 'chemotherapeutics agents', and 'surgery in advanced bladder cancer'. At the end of our literature research we selected 141 articles complying with the aim of the review. The results showed that it has been many years since the MVAC (methotrexate, vinblastine, adriamycin, cisplatin) regimen was first developed. The use of cisplatin-based combination chemotherapy is associated with significant toxicity and produces long-term survival in only approximately 15-20% of patients. Gemcitabine + cisplatin represents the gold standard in the treatment of metastatic bladder cancer. In conclusion, the optimal approach in the management of advanced urothelial cancer continues to evolve. Further progress relies on the expansion of research into tumor biology and an understand...Continue Reading

References

Jul 11, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P J LoehrerB A Lowe
Nov 6, 1991·Journal of the National Cancer Institute·P A Seligman, E D Crawford
Jun 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C J LogothetisR G Kilbourn
Nov 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W G HarkerF M Torti
Nov 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B J RothP J Loehrer
Oct 1, 1993·Cancer Treatment Reviews·R PazdurM N Raber
Feb 1, 1994·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C F PolleraF Calabresi
Jan 9, 1997·Nature·R J CoteD G Skinner
May 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A McCaffreyD F Bajorin
Nov 18, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W M StadlerF A Dorr
Dec 13, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J MooreN Murray
Oct 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L SengeløvS A Engelholm
Dec 16, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·V LorussoM De Lena
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J ByrneB W Robinson
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D F BajorinM G Boyle
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J MooreL Seymour
Jan 22, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H von der MaaseL Dogliotti
Apr 28, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D KaufmanW Stadler
Feb 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P SteinD G Skinner
Mar 21, 2001·The Journal of Urology·G DalbagniV Reuter
Mar 12, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D PectasidesA Athanassiou
Aug 7, 2003·The Lancet Oncology·Syed A Hussain, Nicholas D James
Jul 22, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hans von der MaaseMichael Arning
Jan 19, 2006·Japanese Journal of Clinical Oncology·Takeshi TakahashiOsamu Ogawa
Sep 8, 2006·The New England Journal of Medicine·Ken A OlaussenUNKNOWN IALT Bio Investigators
Jan 19, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J BellmuntUNKNOWN Spanish Oncology Genitourinary Group
Mar 21, 2007·European Urology·Takashige AbeKatsuya Nonomura

❮ Previous
Next ❯

Citations

Mar 18, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Cheng-Le ZhuangZhi-Ming Cai
Jul 20, 2016·Cancer Biomarkers : Section a of Disease Markers·Anbang HeYuchen Liu
Aug 16, 2016·Journal of Experimental & Clinical Cancer Research : CR·Anbang HeHongbing Mei
Jun 18, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Shiqing ZhangHongbo Guo
Nov 1, 2017·Journal of Experimental & Clinical Cancer Research : CR·Chengle ZhuangYaoting Gui
Jan 21, 2018·Journal of Translational Medicine·Zhen-Fei ZhangJue-Yu Zhou
Apr 6, 2019·International Urology and Nephrology·WeiPu MaoJiang Geng
May 22, 2016·Journal of Experimental & Clinical Cancer Research : CR·Yonghao ZhanWeiren Huang
Jul 18, 2019·Technology in Cancer Research & Treatment·Xin HuXiaowen Hu
Jun 4, 2020·Chemical Biology & Drug Design·Shiming ZhouJialei Wang
Oct 3, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Junhao LinWeiren Huang
May 28, 2019·Journal of Cellular Physiology·Wei-Ling LvXiao-Yong Song
Dec 4, 2012·Cancer Research·Deepika DhawanDeborah W Knapp
Oct 2, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yongjun QuanXiaodong Zhang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.